[HTML][HTML] Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy

R Dong, M Zhang, Q Hu, S Zheng… - International …, 2018 - spandidos-publications.com
Galectin-3 is a member of the galectin family, which are β‑galactoside‑binding lectins with≥
1 evolutionary conserved carbohydrate‑recognition domain. It binds proteins in a …

Immunohistochemistry in the pathologic diagnosis and management of thyroid neoplasms

A Crescenzi, Z Baloch - Frontiers in endocrinology, 2023 - frontiersin.org
The use of immunohistochemistry cannot be underestimated in the everyday practice of
thyroid pathology. It has evolved over the years beyond the traditional confirmation of thyroid …

[HTML][HTML] Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer

V Arcolia, F Journe, F Renaud… - Oncology …, 2017 - spandidos-publications.com
Currently, fine‑needle aspiration is the most frequently used pre‑operative technique for
diagnosis of malignant thyroid tumors, however, pathologists are unable to reach efficient …

Galectin-1 is a diagnostic marker involved in thyroid cancer progression

V Arcolia, F Journe, A Wattier… - International …, 2017 - spandidos-publications.com
Fine-needle aspiration (FNA) is the most commonly used pre-operative technique for
diagnosis of malignant thyroid tumor. However, many benign lesions, with indeterminate …

The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination

H Ma, S Xu, J Yan, C Zhang, S Qin, X Wang… - Polish Journal of …, 2014 - termedia.pl
Aim of the study is to evaluate the expression of CK19, galectin-3, HBME-1, CD56, claudin-1
and neutrophil gelatinase-associated lipocalin (NGAL) in papillary thyroid carcinoma (PTC) …

[HTML][HTML] Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma …

H Ma, J Yan, C Zhang, S Qin, L Qin, L Liu… - … journal of clinical and …, 2014 - ncbi.nlm.nih.gov
The aim of this study was to evaluate the expression of papillary thyroid carcinoma (PTC)-
associated tumor markers in follicular epithelial dysplasia showing PTC-like nuclear …

Galectin-3 performance in histologic and cytologic assessment of thyroid nodules: A systematic review and Meta-analysis

P Trimboli, C Virili, F Romanelli, A Crescenzi… - International journal of …, 2017 - mdpi.com
The literature on Galectin-3 (Gal-3) was systematically reviewed to achieve more robust
information on its histologic reliability in identifying thyroid cancers and on the concordance …

Evaluation of diagnostic utility of immunohistochemistry markers of TROP-2 and HBME-1 in the diagnosis of thyroid carcinoma

N Zargari, M Mokhtari - European thyroid journal, 2019 - etj.bioscientifica.com
Objective: The diagnosis of thyroid tumors is based on histologic features, but the distinction
between benign and malignant thyroid lesions is somehow difficult, especially in lesions …

Diagnostic value of TROP-2 and CK19 expression in papillary thyroid carcinoma in both surgical and cytological specimens

AG Abdou, M Shabaan, R Abdallha… - Clinical …, 2019 - journals.sagepub.com
Papillary thyroid carcinoma (PTC) represents the most common primary malignant thyroid
tumor and its diagnosis is dependent on the presence of classic nuclear features that are …

[HTML][HTML] Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma

Z Liu, X Li, L Shi, Y Maimaiti, T Chen, Z Li… - … journal of clinical and …, 2014 - ncbi.nlm.nih.gov
Objective: To assess usefulness of cytokeratin 19 (CK19), thyroperoxidase (TPO), Hector
Battifora mesothelial epitope-1 (HBME-1) and galectin-3 (GAL3) in evaluation of aggressive …